Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 2
2005 3
2006 1
2008 2
2009 3
2010 6
2011 5
2012 4
2013 2
2014 6
2015 3
2016 5
2017 5
2018 6
2019 6
2020 7
2021 3
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Repurposing Verapamil to Enhance Killing of T-ALL Cells by the mTOR Inhibitor Everolimus.
Silic-Benussi M, Sharova E, Corradin A, Urso L, Raimondi V, Cavallari I, Buldini B, Francescato S, Minuzzo SA, D'Agostino DM, Ciminale V. Silic-Benussi M, et al. Among authors: ciminale v. Antioxidants (Basel). 2023 Mar 3;12(3):625. doi: 10.3390/antiox12030625. Antioxidants (Basel). 2023. PMID: 36978873 Free PMC article.
MiR-150 in HTLV-1 infection and T-cell transformation.
D'Agostino DM, Raimondi V, Silic-Benussi M, Ciminale V. D'Agostino DM, et al. Among authors: ciminale v. Front Immunol. 2022 Aug 16;13:974088. doi: 10.3389/fimmu.2022.974088. eCollection 2022. Front Immunol. 2022. PMID: 36072598 Free PMC article. Review.
mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells.
Silic-Benussi M, Sharova E, Ciccarese F, Cavallari I, Raimondi V, Urso L, Corradin A, Kotler H, Scattolin G, Buldini B, Francescato S, Basso G, Minuzzo SA, Indraccolo S, D'Agostino DM, Ciminale V. Silic-Benussi M, et al. Among authors: ciminale v. Redox Biol. 2022 May;51:102268. doi: 10.1016/j.redox.2022.102268. Epub 2022 Feb 24. Redox Biol. 2022. PMID: 35248829 Free PMC article.
Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical Parameters.
Sharova E, Maruzzo M, Del Bianco P, Cavallari I, Pierantoni F, Basso U, Ciminale V, Zagonel V. Sharova E, et al. Among authors: ciminale v. Front Oncol. 2021 Mar 16;11:626104. doi: 10.3389/fonc.2021.626104. eCollection 2021. Front Oncol. 2021. PMID: 33796462 Free PMC article.
Functional properties and sequence variation of HTLV-1 p13.
Omsland M, Silic-Benussi M, Moles R, Sarkis S, Purcell DFJ, Yurick D, Khoury G, D'Agostino DM, Ciminale V, Franchini G. Omsland M, et al. Among authors: ciminale v. Retrovirology. 2020 May 12;17(1):11. doi: 10.1186/s12977-020-00517-1. Retrovirology. 2020. PMID: 32398094 Free PMC article. Review.
Nanoparticles as Tools to Target Redox Homeostasis in Cancer Cells.
Ciccarese F, Raimondi V, Sharova E, Silic-Benussi M, Ciminale V. Ciccarese F, et al. Among authors: ciminale v. Antioxidants (Basel). 2020 Mar 4;9(3):211. doi: 10.3390/antiox9030211. Antioxidants (Basel). 2020. PMID: 32143322 Free PMC article.
70 results